New York, July 21. 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the publication of the report “Diagnostic Imaging Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Modality, Application, and End User” – https://www.reportlinker.com/ p06295661/?utm_source=GNW
Also, the use of artificial intelligence (AI) and analytics in diagnostic imaging equipment is said to be a future trend in the global diagnostic imaging market.
According to the Centers for Disease Control and Prevention (CDC) report, six out of ten Americans live with at least one chronic disease, including heart disease and stroke, cancer and diabetes. Chronic diseases are the leading causes of death and disability in North America. and stand as one of the major health costs.
According to the CDC, major chronic diseases accounted for nearly US$4.1 trillion in annual health care costs in the United States in 2020. Additionally, diagnostic imaging is widely adopted for chronic conditions in the geriatric population, because the population is more vulnerable to the above chronic indications. For example, JMIR publications revealed that the population over the age of 60 is expected to reach 2 billion by 2050 worldwide. Thus, with the increasing prevalence of aging and chronic diseases, it is essential to focus on healthcare innovation to improve healthcare services. For example, innovation in diagnostic imaging with the support of information and communication technologies (ICT) has been used in several settings that help individuals better diagnose, treat and manage chronic diseases. Additionally, ICT interventions in diagnostic imaging provide solutions to some of the challenges associated with aging and chronic disease.
Osteoporosis is a major health problem worldwide and is responsible for a heavy clinical and financial burden due to increased life expectancy. In addition, osteoporosis increases the risk of falls, fractures, hospitalization and death.
The age-standardized prevalence of osteoporosis among the European population is 12% for women and 12.2% for men aged 50-79, according to statistics from the National Library of Medicine in 2020. Therefore, it is mandatory to carry out clinical evaluations for early diagnosis and to prevent the onset of complications. Several diagnostic imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI) and ultrasound imaging provide information on different aspects of the same pathologies for the detection of osteoporosis at an early stage. For example, MRI provides information on various aspects of bone pathophysiology, and its results play a vital role in the early diagnosis of diseases to prevent onset and clinical consequences. The above mentioned factors are responsible for driving the overall global diagnostic imaging market.
Artificial intelligence is helping to improve many aspects of the healthcare industry, and diagnostic imaging technology is one of the areas that would greatly benefit from it. Manufacturers of diagnostic imaging equipment around the world are integrating AI into their products.
For example, in September 2018, Nvidia announced the launch of the Nvidia Clara platform, a combination of software and hardware working together in diagnostic imaging equipment. Such revolutionary technology can meet the challenges of medical instruments and process huge amounts of data generated every second that doctors and scientists can easily interpret.
Additionally, in August 2018, Google’s DeepMind announced the launch of an AI system capable of rapidly detecting more than 50 eye disorders using routine medical scans. DeepMind’s AI assistant for diagnostic imaging can automatically resolve eye-related issues by identifying disease symptoms in seconds and prioritizing patients who seek urgent care.
AI supporting diagnostic imaging equipment plays a vital role in the diagnosis and classification of cancers. AI plays a central role in the automated recognition of features of medical image samples when performing diagnostic imaging tasks.
For example, automated AI applications have improved the qualitative potentials of clinicians, including detecting many tumor lesions at a time in patients, predicting the resulting tumor by referring to the different databases in a short time. time, translation of phenotypic to genotypic variations, and persistent monitoring. of sick. Additionally, AI generalizes disease imaging techniques with minimal errors, enabling earlier and more meaningful disease diagnosis.
The global diagnostic imaging market is segmented on the basis of modality, application, and end user. Based on modality, the market is segmented into endoscopy, computed tomography, x-ray, ultrasound, magnetic resonance imaging (MRI), nuclear imaging, mammography, and others.
X-ray segment is estimated to account for the largest market share from 2022 to 2028. However, computed tomography (CT) segment is likely to register the highest CAGR during the forecast period.
Computed tomography (CT) is an imaging process that customizes special X-ray equipment to generate a sequence of detailed images or scans of areas inside the body. CT scans are considered the most critical diagnostic tool, especially for lung cancer and traumatic brain injury.
The prevalence of these diseases is driving the demand for CT. According to data released by the American College of Chest Physicians in July 2020, lung cancer is one of the most commonly diagnosed cancers. It accounts for 11.6% of the total number of cancer cases worldwide. Worldwide, incidents of lung cancer are expected to increase by 38%, to 2.89 million, by 2030. According to the International Osteoporosis Foundation (IOF) 2019, one in three women and one in five men aged 50 and over suffer from osteoporosis. fractures. About 200 million people are affected by osteoporosis worldwide, resulting in a fracture every three seconds. A CT scan provides 3D images of bones and helps improve diagnosis and orthopedic surgeries. Thus, the growing burden of orthopedic disorders is bolstering the demand for CT scanners in the global diagnostic imaging market.
Market Opportunities of the Global Diagnostic Imaging Market
Government initiatives sanctioning funds and subsidies for diagnostic imaging services to reach globally are expected to create lucrative opportunities for the overall growth of the global diagnostic imaging market in the coming years. WHO works with partners and manufacturers to develop effective solutions to improve diagnostic services in remote locations.
In addition, WHO and its partners provide training programs on the use and management of diagnostic imaging, with a focus on patient safety. For example, in February 2022, Siemens Healthineers announced a partnership with UNICEF that helped improve access to healthcare in sub-Saharan Africa for diagnostic techniques.
Additionally, governments play a vital role in the procurement, pricing and distribution of medical devices worldwide. In addition, governments are undertaking various initiatives to develop health infrastructure, focusing on providing safe and cost-effective medical products through funding and helping to open new health facilities.
For example, in the UK, the National Health Service aims to meet patients’ unmet medical needs in cost-effective ways to improve the country’s economic growth in 2018. Additionally, the Small Business Research Initiative for National Health Service Healthcare provided US$1.1 million to drive adoption of 3D technologies and develop 3D diagnostic imaging systems in 2018. Additionally, the Government of Canada provided US$1,400 per scan and per patient to hospitals, due to a lack of private funding in the country in 2020. Such factors mentioned above are responsible for providing lucrative opportunities to accelerate the growth of the global diagnostic imaging market .
Indian Brand Equity Foundation (IBEF), National Institute of Health (NIH), International Trade Administration (ITA) and Japan Radiological Society (JRS) are some of the primary and secondary sources referred to while preparing the report on global diagnostic imaging. market.
Read the full report: https://www.reportlinker.com/p06295661/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.